Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European …
P Ljungman, R de la Camara, C Robin… - The Lancet infectious …, 2019 - thelancet.com
Cytomegalovirus is one of the most important infections to occur after allogeneic
haematopoietic stem cell transplantation (HSCT), and an increasing number of reports …
haematopoietic stem cell transplantation (HSCT), and an increasing number of reports …
Hematopoietic stem cell transplantation for patients with AML in first complete remission
JJ Cornelissen, D Blaise - Blood, The Journal of the American …, 2016 - ashpublications.org
Postremission therapy in patients with acute myeloid leukemia (AML) may consist of
continuing chemotherapy or transplantation using either autologous or allogeneic stem …
continuing chemotherapy or transplantation using either autologous or allogeneic stem …
[HTML][HTML] Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
P Kebriaei, H Singh, MH Huls… - The Journal of …, 2016 - Am Soc Clin Investig
BACKGROUND. T cells expressing antigen-specific chimeric antigen receptors (CARs)
improve outcomes for CD19-expressing B cell malignancies. We evaluated a human …
improve outcomes for CD19-expressing B cell malignancies. We evaluated a human …
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
SO Ciurea, MJ Zhang, AA Bacigalupo… - Blood, The Journal …, 2015 - ashpublications.org
We studied adults with acute myeloid leukemia (AML) after haploidentical (n= 192) and 8/8
HLA-matched unrelated donor (n= 1982) transplantation. Haploidentical recipients received …
HLA-matched unrelated donor (n= 1982) transplantation. Haploidentical recipients received …
Modern approaches to HLA-haploidentical blood or marrow transplantation
CG Kanakry, EJ Fuchs, L Luznik - Nature reviews Clinical oncology, 2016 - nature.com
Allogeneic blood or bone-marrow transplantation (alloBMT) is a potentially curative
treatment for a variety of haematological malignancies and nonmalignant diseases …
treatment for a variety of haematological malignancies and nonmalignant diseases …
[HTML][HTML] Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a …
Background Non-T-cell depleted haploidentical hematopoietic stem cell transplantation
(HaploSCT) is being increasingly used in acute lymphoblastic leukemia (ALL) with …
(HaploSCT) is being increasingly used in acute lymphoblastic leukemia (ALL) with …
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell …
The number of HLA-haploidentical hematopoietic cell transplants continues to increase
worldwide due to recent improvements in outcomes, allowing more patients with …
worldwide due to recent improvements in outcomes, allowing more patients with …
[HTML][HTML] Human cytomegalovirus latency and reactivation in allogeneic hematopoietic stem cell transplant recipients
L Stern, B Withers, S Avdic, D Gottlieb… - Frontiers in …, 2019 - frontiersin.org
Human cytomegalovirus (HCMV) reactivation is a major infectious cause of morbidity and
mortality after allogeneic hematopoietic stem cell transplantation (HSCT). HCMV is a …
mortality after allogeneic hematopoietic stem cell transplantation (HSCT). HCMV is a …
Haploidentical stem cell transplantation with posttransplant cyclophosphamide therapy vs other donor transplantations in adults with hematologic cancers: a …
N Gagelmann, A Bacigalupo, A Rambaldi… - JAMA …, 2019 - jamanetwork.com
Importance Use of haploidentical (HAPLO) stem cell transplantation with posttransplant
cyclophosphamide is rapidly increasing in adults with hematologic cancers. However, its …
cyclophosphamide is rapidly increasing in adults with hematologic cancers. However, its …
Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide
TM Robinson, PV O'Donnell, EJ Fuchs, L Luznik - Seminars in hematology, 2016 - Elsevier
Allogeneic blood or bone marrow transplantation (BMT) is a potentially curative therapy for
high-risk hematologic malignancies not curable by standard chemotherapy, but the …
high-risk hematologic malignancies not curable by standard chemotherapy, but the …